Medicine

Despite flimsy evidence, trying these drugs in humans is the only way to know if they will work against COVID-19

The promise of host-response profiling

Cancer medicine generates enormous revenues but marginal benefits for patients

A growing medical subspecialty focuses on the nexus between cancer and heart disease

Next-generation opioids may spring from a tiny fungus protein 

The pharmaceutical industry is in a drug-discovery slump. How much can AI help?

For some of the most common cardiac conditions, medication is a solid alternative 

Researchers dialed down the default number of opioids in two hospitals’ prescription systems—and doctors ended up prescribing fewer pills. Christopher Intagliata reports.

Dozens of compounds approved for other purposes can kill cancer cells selectively

It comes in many types that each require specialized treatment, and scientists are learning to diagnose different varieties

The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses

Even combination therapies do not prevent such pathogens from becoming resistant